Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials
Despite the widespread rollout of vaccines over 2021, the Covid-19 pandemic remains a threat to…
Despite the widespread rollout of vaccines over 2021, the Covid-19 pandemic remains a threat to…
Here’s a list of the public European biotech companies that are worth more than a…
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
With messenger RNA being pushed to the market in record time and Alnylam’s historic approval…
The share price of CureVac has skyrocketed almost fivefold after the Covid-19 vaccine developer priced…
GlaxoSmithKline (GSK) has struck a deal worth up to €1B with the German biotechnology company…
The Federal Republic of Germany will invest €300M in CureVac, the homegrown biotech that is…
Update (29/04/2020): A vaccine developed by the German company BioNTech and its big pharma partner…
The first vaccine against coronavirus disease could one day be made of mRNA. How is…
The German biotech CureVac -- which is developing an mRNA vaccine against coronavirus -- has…
RNA vaccine developer CureVac will receive a grant of up to €8.3M from a global…